BogenschutzMPForcehimesAAPommyJA. (2015) Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol29: 289–299.
2.
Carhart-HarrisRLBolstridgeMRuckerJ. (2016) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry3: 619–627.
3.
Carhart-HarrisRLLeechRHellyerPJ. (2014) The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci8: 20.
4.
CochinovHMJohnstonWMcClementSE. (2016) Dignity and distress towards the end of life across four non-cancer populations. PLOS ONE11: e0147607.
5.
FallerHMSchulerMRichardU. (2013) Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol31: 782–793.
6.
GreenbergJSolomonSPyszczynskiT (1997) Terror management theory of self-esteem and cultural worldviews: Empirical assessments and conceptual refinements. Adv Exp Soc Psychol29: 61–139.
7.
GriffithsRRJohnsonMWCarducciMA. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol30: 1181-1197.
8.
HendricksPSJohnsonMWGriffithsRR (2015) Psilocybin, psychological distress, and suicidality. J Psychopharmacol29: 1041–1043.
9.
JohnsonMWGarcia-RomeuACosimanoMP. (2014) Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol28: 983–992.
10.
LiNLeeBLiuRJ. (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science329: 959–964.
11.
OstuzziGMatchamFDauchyS. (2015) Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst RevCd011006.
12.
RossSBossisAGussJ. (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol30: 1165-1180.
13.
StewartBWWildCP (2014) World Cancer Report 2014. Geneva, Switzerland: WHO Press.
14.
VollenweiderFXKometerM (2010) The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci11: 642–651.
